Malaria vaccine shows promise against relapsing form of the disease
An experimental vaccine that targets a malaria parasite behind a relapsing form of the disease has shown some promise in a small trial. Researchers tested two vaccine candidates, finding that neither had any serious safety concerns, but only one induced a substantial immune response. The parasite Plasmodium vivax is the second most common cause […]
WORLD MALARIA DAY 2022: AMMREN’S ACTIVITY
As part of AMMREN’s activities to mark World Malaria Day 2022, AMMREN embarked on a fieldtrip to the KIntampo Health Research center with journalists to enable them interact with community members, who are beneficiaries of malaria interventions.